CLOSE X

RK Global

MISSED CALL NO 7412074708
Search
Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2356.8025.6 (+1.1 %)
PREV CLOSE ( ) 2331.20
OPEN PRICE ( ) 2384.95
BID PRICE (QTY) 2354.60 (1)
OFFER PRICE (QTY) 2358.00 (5)
VOLUME 1128
TODAY'S LOW / HIGH ( )2352.65 2397.00
52 WK LOW / HIGH ( )2218 3515.95
NSE2353.3019.9 (+0.85 %)
PREV CLOSE( ) 2333.40
OPEN PRICE ( ) 2377.00
BID PRICE (QTY) 2353.20 (39)
OFFER PRICE (QTY) 2355.10 (11)
VOLUME 44285
TODAY'S LOW / HIGH( ) 2351.00 2396.90
52 WK LOW / HIGH ( )2217.6 3515.7
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
Renu Sud Karnad - Chairman Bhushan Akshikar - Managing Director
Registered Office

Address Gsk House, Dr. Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com / in.investorquery@gsk.com

Website www.gsk-india.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
07Mar GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
02Mar GlaxoSmithKline Pharmaceuticals inform
In compliance with Regulation 30 of Securities and Exchange Board of Ind..
02Mar Appointment of Director
Inter alia, have approved the appointment Mr. Ronojit Biswas (DIN 076848..
23Feb GlaxoSmithKline Pharmaceuticals infor
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
03Feb GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 30 read with para A of Part A of Schedule III of..
MORE
Financials
in Crores
QTR Dec 25 ANNUAL 25
Net Profit277.18919.06
Gross Profit 377.89 1248.44
Operating Profit 399.41311.85
Net Sales 1022.593723.49
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  13982.00 (6.20%)
M.Cap ( in Cr)17929.77
Abbott India (BSE)
up  25863.90 (0.79%)
M.Cap ( in Cr)54932.21
Astrazeneca Pharma I (BSE)
up  7914.00 (1.77%)
M.Cap ( in Cr)19766.25
Acutaas Chemicals (BSE)
up  2330.00 (5.48%)
M.Cap ( in Cr)19079.25
NGL Fine-Chem (BSE)
up  2303.10 (4.14%)
M.Cap ( in Cr)1422.86
MORE
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.66%
MUTUAL FUNDS/UTI 4.77%
FI/BANKS/INSURANCE 2.67%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
Nippon India Pharma Fund(G)3.63
360 ONE Quant Fund-Reg(G)3.13
Bajaj Finserv Healthcare Fund-Reg(G)2.59
Aditya Birla SL MNC Fund-Reg(G)2.48
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)2.37
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Reg(G)2.36
ICICI Pru Quant Fund(G)2.34
MORE
Call Us +91 -33 40142930
Email Us care.kolkata@rkglobal.in
Corporate Office Flat No.5 Sagar Apartment 6 Tilak Marg, New Delhi 110 001
Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Company
Quick LInks

Copyrights 2020 © rkglobal.in - All Right Reserved

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.